| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.004 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.006 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.007 |